论文部分内容阅读
广州侨光制药厂研究所研究试制的肝安注射液,处方与美国Hepat Amine注射液相同,是内含15种氨基酸的复合溶液,供静脉滴注。 1986年,侨光制药厂与天津津北生化药厂经过考察和洽谈,认定津北生化药厂氨基酸大输液车间厂房设备已达到国内先进水平,技术力量雄厚,管理符合G.M.P要求,具备生产肝安注射液的条件。同年10月经双方厂家商定,决定以横向联营形式共同生产肝安注射液。从此,我国北方有了全国第二家生产肝安注射液的企业—天津津北生化制药厂。由该厂生产的肝安注射液目前已经投放市场,受到用户欢迎。
Guangzhou Qiaopu Pharmaceutical Research Institute of the trial production of liver injection, prescription and the United States Hepat Amine injection is the same, is a composite solution containing 15 kinds of amino acids for intravenous drip. In 1986, Qiaoguang Pharmaceutical Factory and Tianjin Jinbei Biochemical Pharmaceutical Factory investigated and negotiated that it had reached the advanced domestic level with the advanced equipment of amino acid infusion plant in Jinbei Biochemical Pharmaceutical Factory. With strong technical force, the management met GMP requirements, Injection conditions. October the same year by the manufacturers agreed upon by both parties decided to horizontal joint venture in the form of liver injection. Since then, the north of our country has the country’s second enterprise producing liver injection - Tianjin Jinbei Biochemical Pharmaceutical Factory. Liver safety injection produced by the plant is currently on the market, welcomed by users.